Pulmatrix, Inc. (PULM) intrinsic value & 10-year financials
Pulmatrix, Inc. (PULM) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.36
- Market cap
- $5.0M
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- 32.2%
- ROIC (10-yr avg)
- -44.0%
- Free cash flow (FY2025)
- —
PULM 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$5.2M | -$1.41 | — | — | — |
| FY2024 | $7.8M | -$9.6M | -$2.62 | -$11.1M | -125.1% | — |
| FY2023 | $7.3M | -$14.1M | -$3.87 | -$16.7M | -202.0% | -197.5% |
| FY2022 | $6.1M | -$18.8M | -$5.46 | -$19.4M | -312.1% | — |
| FY2021 | $5.2M | -$20.2M | — | -$19.9M | -390.2% | 300.1% |
| FY2020 | $12.6M | -$19.3M | — | -$12.8M | -78.1% | 244.1% |
| FY2019 | $7.9M | -$20.6M | — | $3.2M | -261.6% | — |
| FY2018 | $153.0K | -$20.6M | — | -$16.8M | -13288.2% | -215.4% |
| FY2017 | $335.0K | -$18.1M | — | -$14.6M | -5216.4% | -178.9% |
| FY2016 | $835.0K | -$27.8M | — | -$13.7M | -2978.0% | -216.5% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Pulmatrix, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Pulmatrix, Inc. has historically struggled to out-earn its cost of capital, averaging just -0.4% ROIC.
Pulmatrix, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Pulmatrix, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-46.83 per share.